When bacteria cells replicate, they do so a little differently than human cells do. They don't undergo mitosis, a splitting that involves construction ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

A team of scientists has identified an enzyme called PurF as a new drug target for tuberculosis, offering a fresh line of ...

The story seems to get stranger the further scientists delve into the origins of life. For many years, scientists thought ...

When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...

Streptococcus pneumoniae is a main cause of bacterial pneumonia worldwide. It can also cause ear and sinus infections and, in ...

Maize serves as a vital model species for advancing our understanding of plant biology, yet many mysteries remain about the ...

For decades, large portions of the human genome were labeled "junk DNA." New research from Western University and London ...

Researchers have revealed how bacteria precisely control the genes that trigger cell division. The study shows that the MraZ protein, which normally forms a donut-shaped structure, must bend and ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Christopher H. Contag explores how tissue regeneration involves organized interactions beyond just cell replacement, highlighting two emerging technologies ...